ACCENTIA BIOPHARMACEUTICALS INC Stock-Based Compensation
ACCENTIA BIOPHARMACEUTICALS INC reported Stock-Based Compensation of $3.84 million for the 12-month period ending 2012-09-30, per its 10-K filed 2012-12-26.
Discontinued › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2012-12-26
- ACCENTIA BIOPHARMACEUTICALS INC share-based payment arrangement, noncash expense for the quarter ending 2012-09-30 was $127.20K, a 54.66% decline year-over-year.
- ACCENTIA BIOPHARMACEUTICALS INC share-based payment arrangement, noncash expense for the quarter ending 2012-06-30 was $134.83K, a 92.47% decline year-over-year.
- ACCENTIA BIOPHARMACEUTICALS INC share-based payment arrangement, noncash expense for the quarter ending 2012-03-31 was $3.45M, a 1.88% increase year-over-year.
- ACCENTIA BIOPHARMACEUTICALS INC share-based payment arrangement, noncash expense for the quarter ending 2011-12-31 was $127.88K, a 98.82% decline year-over-year.
- ACCENTIA BIOPHARMACEUTICALS INC share-based payment arrangement, noncash expense for fiscal 2012 was $3.84M, a 76.45% decline from fiscal 2011.
- ACCENTIA BIOPHARMACEUTICALS INC share-based payment arrangement, noncash expense for fiscal 2011 was $16.31M, a 3280.95% increase from fiscal 2010.
- ACCENTIA BIOPHARMACEUTICALS INC share-based payment arrangement, noncash expense for fiscal 2010 was $482.31K.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2012-09-30 | $127.20K derived: 10-K 12 month − 10-Q 9 month · filed 2012-12-26 | $262.02K derived: sum of 2 quarters · filed 2012-12-26 | $3.71M derived: sum of 3 quarters · filed 2012-12-26 | $3.84M 10-K · filed 2012-12-26 |
| 2012-06-30 | $134.83K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-08-14 | $3.58M derived: sum of 2 quarters · filed 2012-08-14 | $3.71M 10-Q · filed 2012-08-14 | $3.99M derived: sum of 4 quarters · filed 2012-12-26 |
| 2012-03-31 | $3.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-05-15 | $3.58M 10-Q · filed 2012-05-15 | $3.86M derived: sum of 3 quarters · filed 2012-12-26 | $5.65M derived: sum of 4 quarters · filed 2012-12-26 |
| 2011-12-31 | $127.88K 10-Q · filed 2012-02-10 | $408.45K derived: sum of 2 quarters · filed 2012-12-26 | $2.20M derived: sum of 3 quarters · filed 2012-12-26 | $5.59M derived: sum of 4 quarters · filed 2012-12-26 |
| 2011-09-30 | $280.56K derived: 10-K 12 month − 10-Q 9 month · filed 2012-12-26 | $2.07M derived: sum of 2 quarters · filed 2012-12-26 | $5.46M derived: sum of 3 quarters · filed 2012-12-26 | $16.31M 10-K · filed 2012-12-26 |
| 2011-06-30 | $1.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-08-14 | $5.18M derived: sum of 2 quarters · filed 2012-08-14 | $16.03M 10-Q · filed 2012-08-14 | $16.06M derived: sum of 4 quarters · filed 2012-08-14 |
| 2011-03-31 | $3.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-05-15 | $14.24M 10-Q · filed 2012-05-15 | $14.27M derived: sum of 3 quarters · filed 2012-05-15 | |
| 2010-12-31 | $10.85M 10-Q · filed 2012-02-10 | $10.88M derived: sum of 2 quarters · filed 2012-02-10 | ||
| 2010-09-30 | $32.28K derived: 10-K 12 month − 10-Q 9 month · filed 2011-12-19 | $482.31K 10-K · filed 2011-12-19 | ||
| 2010-06-30 | $450.03K 10-Q · filed 2011-08-12 |